C WorldWide Group’s Bristol-Myers Squibb BMY Stock Holding History

C WorldWide Group’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-120,199	Closed	-$7.46M	–	124
2018 Q3	$7.46M	Hold	120,199	–	–	0.1%	49
2018 Q2	$6.65M	Sell	120,199 -63,208	-34%	-$3.41M	0.09%	54
2018 Q1	$11.6M	Sell	183,407 -30,045	-14%	-$1.93M	0.18%	34
2017 Q4	$13.1M	Sell	213,452 -43,579	-17%	-$2.73M	0.19%	35
2017 Q3	$16.4M	Sell	257,031 -9,981	-4%	-$583K	0.23%	33
2017 Q2	$14.9M	Buy	+267,012	New	+$14.5M	0.23%	37

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

C WorldWide Group's BMY Position: Q4 2018 in Review

C WorldWide Group sold out of Bristol-Myers Squibb (BMY) in Q4 2018, closing a stake of 120,199 shares — an estimated $7.46M sold.

C WorldWide Group first reported a position in BMY in Q2 2017 and held it in 6 quarters. The position peaked at $16.4M in Q3 2017. 1,766 funds tracked by Wall St. Rank hold BMY as of Q4 2018.

C WorldWide Group reported no remaining Bristol-Myers Squibb position as of Q4 2018 after selling out during the quarter.
C WorldWide Group sold 120,199 Bristol-Myers Squibb shares in Q4 2018, an estimated $7.46M.
C WorldWide Group first reported a position in Bristol-Myers Squibb in Q2 2017 and held it in 6 quarters.
C WorldWide Group's Bristol-Myers Squibb position peaked at $16.4M in Q3 2017.
1,766 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2018.

Based on C WorldWide Group's 13F filing for Q4 2018, filed 12 Feb 2019.